Vision RT
Private Company
Total funding raised: $20.5M
Overview
Vision RT is the pioneer and market leader in Surface Guided Radiation Therapy (SGRT), a technology that uses 3D cameras to track patient position without physical markers or ionizing radiation. With over 3,000 systems installed globally, including in 24 of the top 25 US cancer hospitals, the company's platform addresses critical needs in radiotherapy: enhancing patient safety, improving treatment accuracy, and increasing clinical workflow efficiency. The company has a global presence, nearly 400 employees, and a growing portfolio that extends from patient setup to real-time dose visualization, positioning it at the forefront of innovation in radiation oncology.
Technology Platform
Surface Guided Radiation Therapy (SGRT) platform using non-invasive, non-ionizing 3D surface imaging for real-time patient tracking and motion management throughout the radiotherapy workflow. Includes systems for CT simulation (SimRT), treatment planning (MapRT), treatment delivery (AlignRT), and real-time dose visualization (DoseRT).
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Vision RT is the pioneer and market leader in Surface Guided Radiation Therapy (SGRT). Competition includes other specialized SGRT providers (e.g., C-RAD) and major linear accelerator vendors (e.g., Varian, a Siemens Healthineers company, and Elekta) who may develop or bundle their own surface imaging solutions. Vision RT's deep focus, extensive clinical evidence, and broad platform integration are key differentiators.